vers la météo de la validation par utilisateur
+------------------------COMP:V_PASS-N(from)------------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------COMP:V_PASS-N(from)------------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | +------------------COMP:V_PASS-N(in)------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | +------------------COMP:V_PASS-N(in)------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------COMP:V_PASS-N(from)------------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ | +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------COMP:V_PASS-N(from)------------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ | +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+----------------SUBJ:V-N---------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+----------------SUBJ:V-N---------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+----------------SUBJ:V-N---------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------COMP:N-N(from)--------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+----------------SUBJ:V-N---------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------COMP:N-N(from)--------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------COMP:N-N(in)--------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------COMP:N-N(in)--------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------COMP:V_PASS-N(from)------------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------------COMP:N-N(from)--------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------COMP:V_PASS-N(from)------------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------------COMP:N-N(from)--------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+----------------SUBJ:V-N---------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+----------------SUBJ:V-N---------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+----------------SUBJ:V-N---------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------------COMP:N-N(from)--------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+----------------SUBJ:V-N---------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------------COMP:N-N(from)--------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+ +--------------------COMP:N-N(from)--------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+ +--------------------COMP:N-N(from)--------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | +------------------COMP:V_PASS-N(in)------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | +------------------COMP:V_PASS-N(in)------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------------COMP:N-N(from)--------------------+ | | | +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------------COMP:N-N(from)--------------------+ | | | +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +COMP:V_PASS-+ | +MOD_ATT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------COMP:V_PASS-N(from)------------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ | +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------COMP:V_PASS-N(from)------------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ | +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------COMP:V_PASS-N(in)------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,adipocytes) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ +------------------------COMP:V_PASS-N(from)------------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(from) (involve,__SP__) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+----------------SUBJ:V-N---------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+----------------SUBJ:V-N---------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+----------------SUBJ:V-N---------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------COMP:N-N(from)--------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+----------------SUBJ:V-N---------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------COMP:N-N(from)--------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------COMP:N-N(in)--------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------COMP:N-N(in)--------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------------COMP:N-N(from)--------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------------COMP:N-N(from)--------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+----------------SUBJ:V-N---------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+----------------SUBJ:V-N---------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+----------------SUBJ:V-N---------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------------COMP:N-N(from)--------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+----------------SUBJ:V-N---------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,mRNA(s)) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +--------------------COMP:N-N(from)--------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+ +--------------------COMP:N-N(from)--------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------SUBJ:V-N-----------------------------+ +--------------------COMP:N-N(from)--------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+------COMP:N-N(from)------+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) COMP:N-N(from) (mRNA(s),__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------COMP:N-N(in)--------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ +COMP:N-N(from+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(from) (adipocytes,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------------COMP:N-N(from)--------------------+ | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+COMP:N-N(in)+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) COMP:N-N(in) (mRNA(s),adipocytes) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------------COMP:N-N(from)--------------------+ | | | +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+------------------------------------------------------------------------COMP:V_PASS-N(in)-----------------------------------------------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +--------------------COMP:N-N(from)--------------------+ | | | +--------------COMP:N-N(in)--------------+ | | +-------------------APPOS-------------------+ | +--------------------------SUBJ:V_PASS-N--------------------------+ +--------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ-+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +COMP:V_PASS-+ | +MOD_ATT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) is involved in expression of __SP__ __NODE__ mRNA(s) in adipocytes from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V_PASS-N (involve,administration) COMP:V_PASS-N(in) (involve,expression) COMP:V_PASS-N(in) (involve,__SP__) COMP:N-N(of) (expression,mRNA(s)) COMP:N-N(in) (expression,adipocytes) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA(s),__SP__) MOD_ATT:N-ADJ (mRNA(s),__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
